AzTrials
AzTrials

Cigarette Smoking-Related CarcinomaNCT05227027

Pilot Trial of a Game Embedded in a Smartphone App for Smoking Cessation

A study testing Game Module and Smoke Free smartphone application in people with Cigarette Smoking-Related Carcinoma, run by University of California, San Francisco at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluates the effects of a video game embedded in a commercially available mobile application (app) for smoking cessation. Smokers are increasingly turning to mobile health apps for assistance with quitting smoking, and there is a critical need for strategies to engage app users to increase retention and… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Cigarette Smoking-Related Carcinoma
What is being tested?
Game Module and Smoke Free smartphone application
Could I receive a placebo?
No, everyone receives an active treatment
How many people
500 participants
Where
1 siteUnited States
Study dates
9 Feb 2022to 31 May 2022
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Provides electronic informed consent.
  • Male or female, aged 18 and older
  • Has downloaded and opened the Smoke Free app
  • A smoker of at least 1 cigarette per day
  • Plans to quit smoking within the next 7 days
  • Speaks, reads, and writes English
  • Lives in the United States

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of California San Francisco

    San Francisco, California, 94143

Other trials in United States

About this study

Official title: Influence of a Game Embedded in a Smartphone App for Smoking Cessation on User Engagement: A Randomized Pilot Trial

This study evaluates the effects of a video game embedded in a commercially available mobile application (app) for smoking cessation. Smokers are increasingly turning to mobile health apps for assistance with quitting smoking, and there is a critical need for strategies to engage app users to increase retention and efficacy. Video games are designed to increase users' motivation and engagement, which in turn may increase their exposure and adherence to a smoking cessation program. The hypothesis is that the game increases engagement, retention, and smoking abstinence rates compared with a core version of the app without the game. A two-arm individually randomized pilot trial of 500 adult smokers will test this hypothesis, comparing outcomes for participants randomized to receive the core app plus embedded game with participants randomized to receive the core app only. Primary outcomes relate to user engagement with the app. Secondary outcomes relate to user engagement, efficacy (smoking abstinence), and user satisfaction.

Read the detailed description

PRIMARY OBJECTIVES:

  1. Augment an existing smartphone cessation app for smoking cessation with a video game to increase user engagement.

II. Test the feasibility, engagement, and early efficacy of the 'gamified' app, compared to one without gamification.

OUTLINE:

Participants are recruited through the Smoke Free smartphone app and randomized to 1 of 2 arms.

ARM I: Participants receive an educational intervention through the Smoke Free application (core app) with the embedded video game module. Participants complete questionnaires and may undergo saliva sample collection, if they report being smoke-free on follow-up.

ARM II: Participants receive an educational intervention through the Smoke Free application without the video game module (core app only). Participants complete questionnaires and may undergo saliva sample collection, if they report being smoke-free on follow-up.

Being tested
Game Module, Smoke Free smartphone application

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Game ModuleBehavioural

    Also called In-application game module

    Receive access to the the game module through the free, 'Smoke Free' smartphone application

  • Smoke Free smartphone applicationBehavioural

    Also called Educational intervention

    Receive educational intervention through the free 'Smoke Free' smartphone application (core version of the app)

Study groups in NCT05227027
Study groupRoleWhat they receive
Education plus game moduleExperimentalParticipants receive an educational intervention through the Smoke Free application with the embedded game module. Participants complete questionnaires and may undergo saliva sample collection, if they report being smoke-free on follow-up.
Receives: Behavioral: Game Module; Behavioral: Smoke Free smartphone application
Education module onlyActive comparatorParticipants receive an educational intervention through the Smoke Free application only (core app only). Participants complete questionnaires and may undergo saliva sample collection, if they report being smoke-free on follow-up.
Receives: Behavioral: Smoke Free smartphone application

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Unique App Sessions

    Number of times the app was opened; passively collected by the app and averaged in analysis to calculate mean number of app opens by study group over the study period. A new session is defined as use of the app after at least 30 minutes of inactivity.

    Measured: Enrollment through 56 days after participant's selected quit date (56 to 63 days total)

  2. Minutes of App Usage Per Session

    Passively collected by the app and averaged in analysis among those with a session to calculate mean number of minutes of usage per session by study group.

    Measured: Enrollment through 56 days after participant's selected quit date (56 to 63 days total)

Secondary outcomes (5)
  1. Unique Days With at Least One App Session

    Number of unique days with at least one app session, passively collected by the app and averaged by study group.

    Measured: Enrollment through 56 days after participant's selected quit date (56 to 63 days total)

  2. Self-reported 7-day Point-prevalence Abstinence at 2 Months

    Proportion of participants who self-report having abstained for the prior 7 days during the 2-month follow-up assessment, assuming missing = smoking.

    Measured: 56 days after participant's selected quit date (56 to 63 days after enrollment)

  3. Self-reported 30-day Point-prevalence Abstinence at 2 Months

    Proportion of participants who who self-report having abstained for the prior 30 days during the 2-month follow-up assessment, assuming missing = smoking.

    Measured: 56 days after participant's selected quit date (56 to 63 days after enrollment)

  4. Satisfaction With App

    Rating of satisfaction with assigned app on a 5-point Likert scale from "Not at all" (1) to "Extremely" (5), assessed in the 2-month follow-up questionnaire. The measure is averaged by study group.

    Measured: 56 days after participant's selected quit date (56 to 63 days after enrollment)

  5. Satisfaction With Game (Intervention Group Only)

    Rating of satisfaction with the game on a 5-point Likert scale from "Not at all" (1) to "Extremely" (5), assessed in the 2-month follow-up questionnaire. The measure is averaged for the intervention group.

    Measured: 56 days after participant's selected quit date (56 to 63 days after enrollment)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Feb 2022
  2. Study start9 Feb 2022
  3. Primary completion31 May 2022
  4. Study completion31 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
500 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05227027
Sponsor's protocol ID
19-29335
Other IDs
NCI-2021-07004, P30AG012839, R21CA238301
Status last verified
Nov 2023
First submitted
26 Jan 2022
Last updated
3 Jan 2024
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • White JS, Salem MK, Toussaert S, Westmaas JL, Raiff BR, Crane D, Warrender E, Lyles C, Abroms L, Thrul J. Developing a Game (Inner Dragon) Within a Leading Smartphone App for Smoking Cessation: Design and Feasibility Evaluation Study. JMIR Serious Games. 2023 Aug 11;11:e46602. doi: 10.2196/46602.

    PubMed 37566442
  • White JS, Toussaert S, Raiff BR, Salem MK, Chiang AY, Crane D, Warrender E, Lyles CR, Abroms LC, Westmaas JL, Thrul J. Evaluating the Impact of a Game (Inner Dragon) on User Engagement Within a Leading Smartphone App for Smoking Cessation: Randomized Controlled Trial. J Med Internet Res. 2024 Oct 30;26:e57839. doi: 10.2196/57839.

    PubMed 39475840

Questions about this trial

What is this clinical trial studying?

A study testing Game Module and Smoke Free smartphone application in people with Cigarette Smoking-Related Carcinoma, run by University of California, San Francisco at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 3 Jan 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Unique App Sessions (time frame: Enrollment through 56 days after participant's selected quit date (56 to 63 days total)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05227027, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in